E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 9/20/2005 in the Prospect News Biotech Daily and Prospect News Convertibles Daily.

CuraGen buys back $23.9 million 6% convertibles

New York, Sept. 20 - CuraGen Corp. said it bought back $23.9 million face amount of its 6% convertible subordinated notes due February 2007 in August and September.

The New Haven, Conn.-based biopharmaceutical company paid $23.8 million for the notes, funding the repurchases with proceeds from its recent sale of common stock.

CuraGen now has $66.2 million of the 6% convertibles and $110 million of its 4% convertible subordinated notes due 2011 outstanding.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.